Amal Ayoub
CEO
Claimed by owner Slate Therapeutics
Former names:
Effervescent Foam System for Treatment of Chronic Sinusitis
Slate Therapeutics
About
Slate Therapeutics is the developer of a novel effervescent foam system for treating chronic sinusitis without leaving behind any implant. The company’s product delivers nano-structured MF locally into every sinus using a dedicated delivery device during office and surgical procedures.
The foam enables sustained drug delivery directly to the nasal mucosa, with or without an implant. The foam is administered into the nasal cavity using a novel delivery system that is designed to be compatible with endoscopic and functional endoscopic sinus surgery delivery lumen and suitable for foam generation.
The foam enables sustained drug delivery directly to the nasal mucosa, with or without an implant. The foam is administered into the nasal cavity using a novel delivery system that is designed to be compatible with endoscopic and functional endoscopic sinus surgery delivery lumen and suitable for foam generation.
Primary Sector
Life Sciences & HealthTech
Products
-
Geographic markets
-
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
1
Investors
1
News
(0)The Team
(4)
AA
GB
Gary Binyamin
Co-founder
TF
Tanhum Feld
Co-founder
EV
Eran Vickus
Co-founder & BOD
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Pre-Seed
Undisclosed
Feb 2022
1 Investors
Undisclosed
Media gallery
(0)Locations
Israel
Locations
Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,